严重的侵入性肺炎球菌感染多重,由较少病毒性血清型1肺炎球菌引起:一个病例报告
Takae Okuno1, Megumi Hamaguchi2, Amano Yoshihiro2
1Department of Internal Medicine, Division of Medical Oncology and Respiratory Medicine, Shimane University Faculty of Medicine, izumo, JPN.
Cureus
|March 24, 2025
概括
一个罕见的,严重的病例的侵入性肺炎球菌病引起的血清型1肺炎球菌在一个老年人突出了肺炎球菌合疫苗 (PCV13) 和肺炎球菌多糖体疫苗 (PPSV23) 的重要性.
科学领域:
- 传染性疾病 传染性疾病
- 疫苗学 疫苗学 疫苗学
- 临床病例报告 临床病例报告
背景情况:
- 侵入性肺炎球菌病 (IPD) 的严重程度因血清型而异.
- 血清型1型肺炎球菌通常会导致不那么严重的疾病,如肺炎,死亡率低.
- 对于血清型1的IPD病例,系统和败血症很少被报告.
研究的目的:
- 报告一种独特而严重的IPD病例,该病例是由血清型1 pneumococcus引起的.
- 通过疫苗接种,强调严重的IPD的潜在可预防性.
- 强调在特定人群中进行肺炎球菌疫苗接种的重要性.
主要方法:
- 一个68岁的男性患者的病例报告.
- 具有全身的IPD的临床表现和诊断发现.
- 讨论1型肺炎球菌及其与疾病严重程度的关联.
主要成果:
- 患者患有严重的IPD,包括败血症,,性心周溢液和肌内.
- 病原体被确定为血清型1肺炎球菌.
- 患者需要长时间住院10个月.
结论:
- 这个案例表明,血清型1肺炎球菌可以导致严重的,危及生命的IPD.
- 用肺炎球菌合疫苗 (PCV13) 和肺炎球菌多糖体疫苗 (PPSV23) 接种疫苗可能会防止这种严重的结果.
- 肺炎球菌疫苗接种对于老年人和免疫力低下的人来说至关重要,以预防严重的IPD.
相关概念视频
Pneumonia III: Complications and Assessment
135
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
135
Pneumonia I: Introduction
201
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
201
Pneumonia II: Pathophysiology
195
The pathophysiology of pneumonia involves the following steps:
195
Pneumonia IV: Management
280
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
280


